Heck Capital Advisors LLC Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Heck Capital Advisors LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm bought 3,260 shares of the healthcare conglomerate's stock, valued at approximately $1,649,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Waycross Partners LLC grew its position in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after buying an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $515,000. Full Sail Capital LLC increased its stake in shares of UnitedHealth Group by 2.1% in the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares in the last quarter. Soros Fund Management LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $39,413,000. Finally, Silvercrest Asset Management Group LLC increased its holdings in shares of UnitedHealth Group by 47.8% in the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNH has been the subject of several analyst reports. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. JPMorgan Chase & Co. decreased their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a research note on Thursday, May 15th. KeyCorp reduced their target price on shares of UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Finally, TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $441.87.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John H. Noseworthy acquired 300 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now owns 6,063 shares in the company, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH traded up $2.49 during trading on Wednesday, hitting $297.49. 15,953,133 shares of the stock traded hands, compared to its average volume of 6,692,837. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The company has a market cap of $269.87 billion, a price-to-earnings ratio of 19.19, a PEG ratio of 1.37 and a beta of 0.56. The business has a 50 day moving average price of $443.90 and a 200 day moving average price of $500.04.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company earned $6.91 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.